Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H JACKSON

Showing results (751-760 of 770) with videos related to

Pageof 77
Sort By:
Health Economics|April 21, 2023
Guidance on the use of complex systems models for economic evaluations of public health interventionsPenny R Breeze, Hazel Squires, Kate Ennis, et al.
Nature Genetics|August 20, 2013
Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma riskDaniel Chubb, Niels Weinhold, Peter Broderick, et al.
Leukemia|July 4, 2018
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysisBrian A Walker, Konstantinos Mavrommatis, Christopher P Wardell, et al.
Leukemia|August 12, 2020
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trialsLuciano J Costa, Benjamin A Derman, Susan Bal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2024
Genomic Classification and Individualized Prognosis in Multiple MyelomaFrancesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, et al.
Blood|June 10, 2018
Identification of novel mutational drivers reveals oncogene dependencies in multiple myelomaBrian A Walker, Konstantinos Mavrommatis, Christopher P Wardell, et al.
Nature Genetics|January 12, 2010
Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia riskDalemari Crowther-Swanepoel, Peter Broderick, Maria Chiara Di Bernardo, et al.
Scientific Reports|January 24, 2017
Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk lociPhilip J Law, Amit Sud, Jonathan S Mitchell, et al.
JCI Insight|December 8, 2022
Biallelic TET2 mutations confer sensitivity to 5'-azacitidine in acute myeloid leukemiaFriedrich Stölzel, Sarah E Fordham, Devi Nandana, et al.
Physical Review Letters|April 6, 2001
Measurement of the charged pion electromagnetic form factorJ Volmer, D Abbott, H Anklin, et al.
Pageof 77

Showing results (751-760 of 770) with videos related to

Sort By:
Pageof 77
Health Economics|April 21, 2023
Guidance on the use of complex systems models for economic evaluations of public health interventionsPenny R Breeze, Hazel Squires, Kate Ennis, et al.
Nature Genetics|August 20, 2013
Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma riskDaniel Chubb, Niels Weinhold, Peter Broderick, et al.
Leukemia|July 4, 2018
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysisBrian A Walker, Konstantinos Mavrommatis, Christopher P Wardell, et al.
Leukemia|August 12, 2020
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trialsLuciano J Costa, Benjamin A Derman, Susan Bal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2024
Genomic Classification and Individualized Prognosis in Multiple MyelomaFrancesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, et al.
Blood|June 10, 2018
Identification of novel mutational drivers reveals oncogene dependencies in multiple myelomaBrian A Walker, Konstantinos Mavrommatis, Christopher P Wardell, et al.
Nature Genetics|January 12, 2010
Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia riskDalemari Crowther-Swanepoel, Peter Broderick, Maria Chiara Di Bernardo, et al.
Scientific Reports|January 24, 2017
Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk lociPhilip J Law, Amit Sud, Jonathan S Mitchell, et al.
JCI Insight|December 8, 2022
Biallelic TET2 mutations confer sensitivity to 5'-azacitidine in acute myeloid leukemiaFriedrich Stölzel, Sarah E Fordham, Devi Nandana, et al.
Physical Review Letters|April 6, 2001
Measurement of the charged pion electromagnetic form factorJ Volmer, D Abbott, H Anklin, et al.
Pageof 77